Regeneron Pharmaceuticals Inc (REGN)
892.10
-1.40
(-0.16%)
USD |
NASDAQ |
Apr 19, 11:59
Regeneron Pharmaceuticals Total Long Term Debt (Quarterly): 1.983B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.983B |
September 30, 2023 | 1.983B |
June 30, 2023 | 1.982B |
March 31, 2023 | 1.982B |
December 31, 2022 | 1.981B |
September 30, 2022 | 1.981B |
June 30, 2022 | 1.981B |
March 31, 2022 | 1.980B |
December 31, 2021 | 1.98B |
September 30, 2021 | 1.980B |
June 30, 2021 | 1.979B |
March 31, 2021 | 1.979B |
December 31, 2020 | 1.978B |
September 30, 2020 | 1.978B |
June 30, 2020 | 1.50B |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 30.72M |
June 30, 2015 | 30.36M |
March 31, 2015 | 144.08M |
December 31, 2014 | 146.77M |
September 30, 2014 | 287.95M |
June 30, 2014 | 282.26M |
March 31, 2014 | 326.67M |
December 31, 2013 | 320.32M |
September 30, 2013 | 314.16M |
June 30, 2013 | 308.12M |
March 31, 2013 | 302.27M |
December 31, 2012 | 296.52M |
September 30, 2012 | 290.96M |
June 30, 2012 | 285.49M |
March 31, 2012 | 280.21M |
December 31, 2011 | 275.02M |
September 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
1.983B
Maximum
Dec 2023
1.538B
Average
1.980B
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 0.00 |
Eli Lilly and Co | 25.23B |
CytomX Therapeutics Inc | 0.00 |
Pfizer Inc | 70.84B |
Puma Biotechnology Inc | 99.66M |